ST6GAL1 and breast carcinoma: A recent study suggests that ST6GAL1 secreted by breast cancer cells in soluble form or as a membrane-bound form within extracellular vesicles (EVs) could complement its intrinsic activity in tumor cells, remodeling surface glycans and promoting tumorigenesis and invasiveness [15].